25Indexed trials
mesh condition
Marijuana Abuse
Intelligence
Marijuana Abuse intelligence: 25 indexed trials, 6 recruiting studies, 22 sponsors across 8 countries.
6Recruiting
22Sponsors
8Countries
Leading sponsors
Medical University of South Carolina20 recruiting
University of Colorado, Denver20 recruiting
Fenix Innovation Group22 recruiting
Hartford Hospital10 recruiting
King's College London10 recruiting
Laboratorio Elea Phoenix S.A.11 recruiting
Massachusetts General Hospital10 recruiting
Michael, Levy M.D.,Ph.D.10 recruiting
National Institute on Drug Abuse (NIDA)10 recruiting
New York State Psychiatric Institute10 recruiting
Radboud University Medical Center10 recruiting
St. Joseph's Healthcare Hamilton10 recruiting
Geographic activity
United States12trials
Canada4trials
Australia2trials
Netherlands1trials
United Kingdom1trials
Israel1trials
France1trials
Argentina1trials
Leading interventions
NTI1642trials
Atomoxetine1trials
Cannabidiol 400 mg/ml1trials
CET/PT1trials
Cannabidiol1trials
Cannabidiol 100 mg/ml1trials
Bupropion1trials
Cannabis oil1trials
Contingency management1trials
Delta-THC1trials
Guanfacine1trials
5:1 CBD/THC1trials
Methodology note
This entity is derived from structured ClinicalTrials.gov conditions and/or MeSH normalization. Counts reflect the current NeuroRisk indexed corpus and are not guaranteed exhaustive global totals.